Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |